You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PM01183

Showing 1 - 25 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Carcinoma Trial in Barcelona, Madrid (Lurbinectedin, Pembrolizumab)

Recruiting
  • Small Cell Lung Carcinoma
  • Barcelona, Spain
  • +4 more
Aug 12, 2022

Pancreas Cancer Trial in Scottsdale (Lurbinectedin 4 MG Injection [Zepzelca])

Recruiting
  • Pancreas Cancer
  • Lurbinectedin 4 MG Injection [Zepzelca]
  • Scottsdale, Arizona
    HonorHealth Research Institute
Aug 8, 2022

Advanced Solid Tumors Trial in Madrid (Lurbinectedin alone, Lurbinectedin+Itraconazole co-administration)

Recruiting
  • Advanced Solid Tumors
  • Lurbinectedin alone
  • Lurbinectedin+Itraconazole co-administration
  • Madrid, Spain
  • +1 more
Sep 27, 2021

Advanced Solid Tumor Trial in Madrid (Lurbinectedin, Bosentan)

Recruiting
  • Advanced Solid Tumor
  • Madrid, Spain
  • +1 more
Sep 27, 2021

Metastatic Sarcoma Trial in Boston (PM01183, Doxorubicin, Gemcitabine)

Completed
Has Results
  • Metastatic Sarcoma
  • PM01183
  • +2 more
  • Boston, Massachusetts
  • +1 more
Feb 9, 2021

Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

Recruiting
  • Advanced Solid Tumors
  • +11 more
  • Boston, Massachusetts
  • +4 more
Dec 12, 2022

Carcinoma, Small Cell Lung Trial in Spain (PM 01183, Atezolizumab)

Recruiting
  • Carcinoma, Small Cell Lung
  • Sevilla, Andalucia, Spain
  • +4 more
Mar 2, 2021

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Atlanta (Lurbinectedin, Palliative Radiation

Not yet recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Atlanta, Georgia
  • +2 more
Apr 12, 2022

Platinum-Resistant Lung Small Cell Carcinoma, Platinum-Sensitive Lung Small Cell Carcinoma, Recurrent Extensive Stage Lung Small

Recruiting
  • Platinum-Resistant Lung Small Cell Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Advanced Solid Tumors Trial in Worldwide (lurbinectedin (PM01183))

Completed
Has Results
  • Advanced Solid Tumors
  • lurbinectedin (PM01183)
  • Santa Monica, California
  • +39 more
Oct 21, 2021

Advanced Solid Tumor Trial (Lurbinectedin for injection)

Not yet recruiting
  • Advanced Solid Tumor
  • Lurbinectedin for injection
  • (no location specified)
Nov 16, 2020

Metastatic Ewing Sarcoma, Recurrent Ewing Sarcoma Trial in Houston (Fine-Needle Aspiration, Irinotecan, Irinotecan

Withdrawn
  • Metastatic Ewing Sarcoma
  • Recurrent Ewing Sarcoma
  • Fine-Needle Aspiration
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Breast Cancer Trial in Spain, United States (PM01183)

Completed
Has Results
  • Breast Cancer
  • PM01183
  • Stanford, California
  • +8 more
Sep 4, 2020

Malignant Pleural Mesothelioma, Advanced Trial in Italy, Switzerland (Lurbinectedin)

Completed
  • Malignant Pleural Mesothelioma, Advanced
  • Alessandria, Italy
  • +7 more
Jul 13, 2021

Small Cell Lung Cancer Trial (Lurbinectedin)

Approved for marketing
  • Small Cell Lung Cancer
  • (no location specified)
Jun 17, 2020

Breast Cancer, Ovarian Cancer, Gynecological Cancer Trial in New York, Madrid, Bellinzona (PM01183 + paclitaxel +/- bevacizumab)

Completed
Has Results
  • Breast Cancer
  • +6 more
  • PM01183 + paclitaxel +/- bevacizumab
  • New York, New York
  • +2 more
Mar 24, 2020

Endometrial Adenocarcinomas, Neuroendocrine Tumors, Small-cell Lung Cancer With Less Than 2 Prior Cytotoxic-containing Lines of

Completed
Has Results
  • Endometrial Adenocarcinomas
  • +2 more
  • Barcelona, Spain
  • +6 more
Feb 24, 2020

Ovarian Cancer Trial in United States (Lurbinectedin (PM01183), Pegylated liposomal doxorubicin (PLD), Topotecan)

Completed
Has Results
  • Ovarian Cancer
  • Lurbinectedin (PM01183)
  • +2 more
  • Peoria, Arizona
  • +27 more
Mar 25, 2020

Relapsed Small Cell Lung Cancer Trial in Worldwide (Irinotecan, Lurbinectedin, Topotecan)

Recruiting
  • Relapsed Small Cell Lung Cancer
  • Joliet, Illinois
  • +94 more
Aug 12, 2022

NSCLC (NSCLC) Trial in New York (Docetaxel, Gemcitabine, Lurbinectedin (PM01183))

Completed
Has Results
  • Non-Small Cell Lung Cancer (NSCLC)
  • New York, New York
    (unnamed)
Sep 4, 2019

Solid Tumors Trial in Spain, United States (lurbinectedin (PM01183))

Completed
Has Results
  • Solid Tumors
  • lurbinectedin (PM01183)
  • Santa Monica, California
  • +15 more
Nov 6, 2019

Small-cell Lung Cancer Trial in Worldwide (Lurbinectedin (PM01183), Doxorubicin (DOX), Cyclophosphamide (CTX))

Completed
Has Results
  • Small-cell Lung Cancer
  • Lurbinectedin (PM01183)
  • +4 more
  • Birmingham, Alabama
  • +159 more
Sep 29, 2021

Depression, Anhedonia Trial in Pittsburgh (device, behavioral, drug)

Recruiting
  • Depression
  • Anhedonia
  • Continuous theta burst stimulation (cTBS)
  • +2 more
  • Pittsburgh, Pennsylvania
    Loeffler Building
Aug 3, 2022

Plaque, Dental, Antimicrobial, Mouthwash Trial (Moringa Oleifera, Chlorhexidine mouthwash, Base formula)

Not yet recruiting
  • Plaque, Dental
  • +3 more
  • Moringa Oleifera
  • +2 more
  • (no location specified)
Apr 5, 2022

Advanced Cancer, Ovarian Cancer, Endometrial Cancer Trial in Spain (PM01183 + olaparib)

Unknown status
  • Advanced Cancer
  • +3 more
  • PM01183 + olaparib
  • Córdoba, Andalucía, Spain
  • +5 more
Jun 21, 2017